Advanced Health Intelligence Ltd
MYZQF
$0.004
-$0.001-20.00%
| Weiss Ratings | MYZQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | MYZQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | MYZQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | MYZQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | -20.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -93.33% | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -39.39% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | MYZQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.01 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Oct 31, 2024 | |||
| 52-Week High Price (Date) | Sep 05, 2024 | |||
| Valuation | MYZQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 16.23M | |||
| Enterprise Value | 18.71M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.05 | |||
| Earnings Per Share Growth | 26.78% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 5.00 | |||
| Price/Book (Q) | -0.44 | |||
| Enterprise Value/Revenue (TTM) | 101.81 | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -2.25 | |||
| Enterprise Value/EBIT | -2.21 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | MYZQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 222.27M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | MYZQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 61 8 6244 0388 | |||
| Address | 71-73 South Perth Esplanade South Perth, WA 6151 | |||
| Website | www.ahi.tech | |||
| Country | Australia | |||
| Year Founded | 2014 | |||
| Profitability | MYZQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -4,616.10% | |||
| Profit Margin | -5,869.33% | |||
| Management Effectiveness | MYZQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -86.02% | |||
| Return on Equity | -- | |||
| Income Statement | MYZQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 277.20K | |||
| Total Revenue (TTM) | 188.80K | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | -4.57M | |||
| EBITDA (TTM) | -8.53M | |||
| EBIT (TTM) | -8.72M | |||
| Net Income (TTM) | -11.08M | |||
| Net Income Avl. to Common (TTM) | -11.08M | |||
| Total Revenue Growth (Q YOY) | -91.39% | |||
| Earnings Growth (Q YOY) | -96.22% | |||
| EPS Diluted (TTM) | -0.05 | |||
| EPS Diluted Growth (Q YOY) | -41.25% | |||
| Balance Sheet | MYZQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 314.30K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 1.13M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -2.14M | |||
| Current Ratio (Q) | 0.200 | |||
| Book Value Per Share (Q) | -$0.01 | |||
| Total Assets (Q) | 4.85M | |||
| Total Current Liabilities (Q) | 5.64M | |||
| Total Debt (Q) | 2.49M | |||
| Total Liabilities (Q) | 7.00M | |||
| Total Common Equity (Q) | -2.14M | |||
| Cash Flow | MYZQF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 59.70K | |||
| Cash from Financing (TTM) | 5.07M | |||
| Net Change in Cash (TTM) | -62.70K | |||
| Levered Free Cash Flow (TTM) | -711.50K | |||
| Cash from Operations (TTM) | -5.16M | |||
